Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression of steroid hormone receptors in BRCA1-associated ovarian carcinomas.

Gynecologic oncology - 1 Apr 2005

Aghmesheh Morteza, Edwards Lyndal, Clarke Christine L, Byth Karen, Katzenellenbogen Benita S, Russell Pamela J, Friedlander Michael, Tucker Katherine M, de Fazio Anna

Abstract excerpt

OBJECTIVE: BRCA1 mutations predispose to cancer in hormone responsive tissues. A predominance of estrogen receptor (ER)-negative breast cancers in BRCA1 mutation carriers and potential interactions between ERalpha and BRCA1 suggest a link between hormones and BRCA1. However, the expression pattern of ERalpha and other hormone receptors in BRCA1-associated ovarian cancer was unknown. METHODS: Twenty-two...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to BRCA1 Protein

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Estrogen Receptor alpha

Share to Estrogen Receptor beta

Share to Ovarian Neoplasms

Share to Receptors, Androgen

Share to Receptors, Progesterone

Share to Receptors, Steroid

Source

Identifiers

PMID: 15790432
DOI: 10.1016/j.ygyno.2004.12.030

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression of steroid hormone receptors in BRCA1-associated ovarian carcinomas.PMID 15790432Read ↗

Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers.Semantic proximity Read ↗

The complex relationship between BRCA1 and ERalpha in hereditary breast cancer.Semantic proximity Read ↗

Androgen pathway dysregulation in BRCA1-mutated breast tumors.Semantic proximity Read ↗

Thyroid Hormone Receptors Predict Prognosis in BRCA1 Associated Breast Cancer in Opposing Ways.Semantic proximity Read ↗

Androgen receptor expression in breast cancer patients tested for BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers.Semantic proximity Read ↗

Increased Progesterone Receptor Expression in Benign Epithelium of BRCA1 -Related Breast CancersSemantic proximity Read ↗

Expression of estrogen receptor beta in the breast carcinoma of BRCA1 mutation carriers.Semantic proximity Read ↗

Proliferation and ovarian hormone signaling are impaired in normal breast tissues from women with BRCA1 mutations: benefit of a progesterone receptor modulator treatment as a breast cancer preventive strategy in women with inherited BRCA1 mutations.Semantic proximity Read ↗

Expression of human estrogen receptor-alpha and -beta, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells.Semantic proximity Read ↗

Preferential allelic expression can lead to reduced expression of BRCA1 in sporadic breast cancers.Semantic proximity Read ↗

Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.